Seer, Inc. (SEER)
NASDAQ$1.94
Market Cap
$115.98M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
832 of 924
Rank in Industry
475 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
SEER Insider Trading Activity
SEER Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $47,495 | 3 | 100 |
Related Transactions
| Horn David R. | PRESIDENT & CFO | 0 | $0 | 1 | $7,940 | $-7,940 |
| Farokhzad Omid | CEO AND CHAIR | 0 | $0 | 1 | $18,044 | $-18,044 |
| Nishar Dipchand | director | 0 | $0 | 1 | $21,512 | $-21,512 |
About Seer, Inc.
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and …
Insider Activity of Seer, Inc.
Over the last 12 months, insiders at Seer, Inc. have bought $0 and sold $47,495 worth of Seer, Inc. stock.
On average, over the past 5 years, insiders at Seer, Inc. have bought $34.35M and sold $56.21M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 40,000 shares for transaction amount of $97,968 was made by Farokhzad Omid (CEO, President and Chair) on 2023‑08‑23.
List of Insider Buy and Sell Transactions, Seer, Inc.
| 2025-02-04 | Sale | Farokhzad Omid | CEO AND CHAIR | 8,068 0.0135% | $2.24 | $18,044 | -1.75% | |
| 2025-02-04 | Sale | Horn David R. | PRESIDENT & CFO | 3,550 0.006% | $2.24 | $7,940 | -1.75% | |
| 2024-06-14 | Sale | Nishar Dipchand | director | 12,109 0.0183% | $1.78 | $21,512 | +11.24% | |
| 2024-03-07 | Sale | Farokhzad Omid | CEO AND CHAIR | 52,857 0.0808% | $2.03 | $107,421 | -6.73% | |
| 2024-02-22 | Sale | Horn David R. | PRESIDENT & CFO | 12,684 0.0213% | $1.58 | $20,024 | +22.93% | |
| 2024-02-22 | Sale | Kogan Elona | CHIEF LEGAL OFFICER | 12,684 0.0213% | $1.58 | $20,024 | +22.93% | |
| 2024-02-05 | Sale | Horn David R. | President and CFO | 3,608 0.0053% | $1.67 | $6,015 | +13.77% | |
| 2023-12-04 | Sale | Kogan Elona Esq. | Chief Legal Officer | 8,182 0.0136% | $1.70 | $13,869 | +5.85% | |
| 2023-08-23 | Farokhzad Omid | CEO, President and Chair | 40,000 0.0641% | $2.45 | $97,968 | -24.69% | ||
| 2023-05-18 | Sale | Thomas Scott D | Chief Commercial Officer | 1,468 0.0023% | $3.56 | $5,224 | -46.54% | |
| 2023-02-21 | Sale | Farokhzad Omid | CEO, President and Chair | 13,840 0.0229% | $4.13 | $57,210 | -33.76% | |
| 2023-02-21 | Sale | Horn David R. | Chief Financial Officer | 5,951 0.0098% | $4.13 | $24,606 | -33.76% | |
| 2023-02-21 | Sale | Kogan Elona Esq. | General Counsel and Secretary | 5,951 0.0098% | $4.13 | $24,603 | -33.76% | |
| 2023-02-07 | Sale | Farokhzad Omid | CEO, President and Chair | 8,379 0.0129% | $4.67 | $39,128 | -35.36% | |
| 2023-02-07 | Sale | Horn David R. | Chief Financial Officer | 3,124 0.0056% | $5.40 | $16,861 | -35.36% | |
| 2023-01-17 | Sale | Farokhzad Omid | CEO, President and Chair | 4,800 0.0071% | $5.12 | $24,573 | -34.38% | |
| 2023-01-17 | Sale | Horn David R. | Chief Financial Officer | 2,602 0.0039% | $5.12 | $13,320 | -34.38% | |
| 2022-12-08 | Sale | Horn David R. | Chief Financial Officer | 18,884 0.0303% | $6.57 | $124,070 | -40.71% | |
| 2022-06-08 | Sale | Kogan Elona Esq. | General Counsel and Secretary | 8,185 0.0128% | $8.91 | $72,923 | -31.84% | |
| 2022-05-27 | Sale | OSTADAN OMEAD | President & COO | 4,441 0.0065% | $8.06 | $35,794 | -27.01% |
Total: 44
*Gray background shows transactions not older than one year
Insider Historical Profitability
<0.0001%
| Farokhzad Omid | CEO AND CHAIR | 1428217 2.389% | $2.77M | 1 | 8 | <0.0001% |
| Invus Public Equities, L.P. | 10 percent owner | 5588366 9.3479% | $10.84M | 1 | 1 | <0.0001% |
| aMoon Growth Fund Limited Partnership | 10 percent owner | 810961 1.3565% | $1.57M | 2 | 1 | <0.0001% |
| MCGUIRE TERRANCE | director | 78947 0.1321% | $153,157.18 | 1 | 0 | <0.0001% |
| AINSLIE LEE S III | 10 percent owner | 22620 0.0378% | $43,882.80 | 1 | 0 | <0.0001% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$12,784,645 | 193 | 20.49% | $108.26M | |
$54,751,750 | 62 | -1.03% | $114.18M | |
$16,245,616 | 40 | 123.58% | $130.89M | |
$294,424,120 | 20 | 1.33% | $110.74M | |
$111,692,551 | 18 | 13.51% | $118.69M |
SEER Institutional Investors: Active Positions
| Increased Positions | 29 | +32.22% | 2M | +6.36% |
| Decreased Positions | 36 | -40% | 3M | -9.26% |
| New Positions | 10 | New | 628,895 | New |
| Sold Out Positions | 12 | Sold Out | 699,756 | Sold Out |
| Total Postitions | 83 | -7.78% | 29M | -2.9% |
SEER Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Softbank Group Corp. | $10,014.00 | 9.17% | 5.14M | 0 | 0% | 2024-12-31 |
| Siren, L.L.C. | $7,800.00 | 7.14% | 4M | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $5,217.00 | 4.78% | 2.68M | +42,256 | +1.6% | 2024-12-31 |
| Tang Capital Management Llc | $4,279.00 | 3.92% | 2.19M | -105,577 | -4.59% | 2024-12-31 |
| Vanguard Group Inc | $4,254.00 | 3.9% | 2.18M | -161,727 | -6.9% | 2024-12-31 |
| Acadian Asset Management Llc | $4,194.00 | 3.84% | 2.15M | -14,713 | -0.68% | 2024-12-31 |
| Renaissance Technologies Llc | $1,645.00 | 1.51% | 843,700 | +179,568 | +27.04% | 2024-12-31 |
| Bridgeway Capital Management, Llc | $1,419.00 | 1.3% | 727,743 | +109,000 | +17.62% | 2024-12-31 |
| D. E. Shaw & Co., Inc. | $1,404.00 | 1.29% | 719,901 | +103,630 | +16.82% | 2024-12-31 |
| Fmr Llc | $1,373.00 | 1.26% | 704,151 | 0 | 0% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
No data is available at this moment.
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.